Raymond James Trust’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $685K | Buy |
6,346
+19
| +0.3% | +$2.07K | 0.01% | 642 |
|
|
2024
Q2 | $687K | Buy |
6,327
+766
| +14% | +$90.3K | 0.02% | 596 |
|
|
2024
Q1 | $734K | Sell |
5,561
-2,895
| -34% | -$362K | 0.02% | 558 |
|
|
2023
Q4 | $1.03M | Sell |
8,456
-421
| -5% | -$47K | 0.03% | 447 |
|
|
2023
Q3 | $996K | Sell |
8,877
-10,991
| -55% | -$1.4M | 0.03% | 422 |
|
|
2023
Q2 | $2.89M | Buy |
19,868
+9,906
| +99% | +$1.35M | 0.08% | 216 |
|
|
2023
Q1 | $1.29M | Buy |
9,962
+35
| +0.4% | +$4.39K | 0.04% | 361 |
|
|
2022
Q4 | $1.27M | Buy |
9,927
+1,403
| +16% | +$163K | 0.04% | 344 |
|
|
2022
Q3 | $891K | Sell |
8,524
-435
| -5% | -$47.7K | 0.03% | 409 |
|
|
2022
Q2 | $941K | Sell |
8,959
-1,382
| -13% | -$164K | 0.03% | 391 |
|
|
2022
Q1 | $1.32M | Buy |
10,341
+1,682
| +19% | +$203K | 0.04% | 350 |
|
|
2021
Q4 | $1.07M | Buy |
8,659
+965
| +13% | +$126K | 0.03% | 411 |
|
|
2021
Q3 | $1.09M | Buy |
7,694
+260
| +3% | +$38.2K | 0.04% | 382 |
|
|
2021
Q2 | $1.16M | Buy |
7,434
+625
| +9% | +$101K | 0.04% | 359 |
|
|
2021
Q1 | $1.06M | Buy |
6,809
+1,035
| +18% | +$160K | 0.04% | 358 |
|
|
2020
Q4 | $864K | Sell |
5,774
-891
| -13% | -$126K | 0.03% | 386 |
|
|
2020
Q3 | $881K | Buy |
6,665
+421
| +7% | +$55K | 0.04% | 352 |
|
|
2020
Q2 | $723K | Sell |
6,244
-99
| -2% | -$11.4K | 0.04% | 368 |
|
|
2020
Q1 | $623K | Sell |
6,343
-619
| -9% | -$81.1K | 0.04% | 356 |
|
|
2019
Q4 | $1.01M | Buy |
6,962
+841
| +14% | +$116K | 0.05% | 302 |
|
|
2019
Q3 | $816K | Buy |
6,121
+385
| +7% | +$49.7K | 0.04% | 347 |
|
|
2019
Q2 | $656K | Buy |
5,736
+555
| +11% | +$65K | 0.04% | 379 |
|
|
2019
Q1 | $642K | Buy |
5,181
+64
| +1% | +$7.27K | 0.04% | 370 |
|
|
2018
Q4 | $515K | Sell |
5,117
-2,323
| -31% | -$261K | 0.03% | 391 |
|
|
2018
Q3 | $949K | Buy |
7,440
+263
| +4% | +$31.3K | 0.05% | 290 |
|
|
2018
Q2 | $777K | Sell |
7,177
-26
| -0.4% | -$2.83K | 0.05% | 312 |
|
|
2018
Q1 | $762K | Buy |
7,203
+20
| +0.3% | +$2.32K | 0.05% | 286 |
|
|
2017
Q4 | $841K | Sell |
7,183
-333
| -4% | -$37.7K | 0.06% | 272 |
|
|
2017
Q3 | $854K | Buy |
7,516
+60
| +0.8% | +$6.93K | 0.06% | 266 |
|
|
2017
Q2 | $929K | Sell |
7,456
-1,799
| -19% | -$213K | 0.07% | 252 |
|
|
2017
Q1 | $1.1M | Buy |
9,255
+32
| +0.3% | +$3.63K | 0.08% | 230 |
|
|
2016
Q4 | $924K | Sell |
9,223
-164
| -2% | -$17.6K | 0.07% | 245 |
|
|
2016
Q3 | $1.19M | Sell |
9,387
-779
| -8% | -$96.2K | 0.1% | 194 |
|
|
2016
Q2 | $1.19M | Buy |
10,166
+223
| +2% | +$25.2K | 0.1% | 187 |
|
|
2016
Q1 | $1.03M | Buy |
9,943
+3,557
| +56% | +$344K | 0.1% | 201 |
|
|
2015
Q4 | $635K | Buy |
6,386
+743
| +13% | +$72.7K | 0.06% | 293 |
|
|
2015
Q3 | $515K | Sell |
5,643
-54
| -0.9% | -$5.41K | 0.06% | 295 |
|
|
2015
Q2 | $604K | Buy |
5,697
+129
| +2% | +$14.3K | 0.06% | 274 |
|
|
2015
Q1 | $635K | Buy |
5,568
+290
| +5% | +$33.1K | 0.07% | 268 |
|
|
2014
Q4 | $581K | Buy |
5,278
+661
| +14% | +$69.7K | 0.06% | 286 |
|
|
2014
Q3 | $451K | Sell |
4,617
-701
| -13% | -$68.9K | 0.05% | 329 |
|
|
2014
Q2 | $537K | Buy |
5,318
+189
| +4% | +$18.4K | 0.06% | 285 |
|
|
2014
Q1 | $471K | Buy |
5,129
+521
| +11% | +$48K | 0.06% | 300 |
|
|
2013
Q4 | $417K | Buy |
4,608
+67
| +1% | +$5.8K | 0.05% | 303 |
|
|
2013
Q3 | $362K | Sell |
4,541
-46
| -1% | -$3.62K | 0.06% | 313 |
|
|
2013
Q2 | $334K | Buy |
+4,587
| New | +$343K | 0.05% | 308 |
|
Other funds holding ZBH
Raymond James Trust's ZBH Position: Q3 2024 in Review
Raymond James Trust increased its Zimmer Biomet (ZBH) stake by 0.3% in Q3 2024, buying an estimated $2.07K and bringing the position to 6,346 shares worth $685K. The position accounts for 0.01% of the portfolio, ranked #642.
Raymond James Trust first reported a position in ZBH in Q2 2013 and has held it in 46 quarters since. The position peaked at $2.89M in Q2 2023. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.
- Raymond James Trust held 6,346 shares of Zimmer Biomet worth $685K as of Q3 2024.
- Raymond James Trust bought 19 Zimmer Biomet shares in Q3 2024, an estimated $2.07K.
- Zimmer Biomet made up 0.01% of Raymond James Trust's portfolio in Q3 2024, its #642 holding.
- Raymond James Trust first reported a position in Zimmer Biomet in Q2 2013 and has held it in 46 quarters since.
- Raymond James Trust's Zimmer Biomet position peaked at $2.89M in Q2 2023.
- 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.
Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.